March 28, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce the addition of Extractables and Leachables (E&L) testing, featuring advanced chemical analysis.
Details
February 5, 2025 – As part of our long-term commitment to supporting medical device and pharmaceutical manufacturing, STERIS is pleased to announce our South Marston, UK laboratory has relocated to Swindon, UK. The new laboratory supports the increased demand in volume and complexity of medical devices and pharmaceuticals in the region.
Details
January 10, 2025 – As part of our long-term commitment to supporting global healthcare product manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory now offers a sustainable approach to bacterial endotoxin testing through the use of recombinant cascade reagents.
Details
November 21, 2024 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS is pleased to announce our Brooklyn Park, Minnesota, USA laboratory ISO 17025 accreditation now includes product and package testing services.
Details
October 17, 2024 – As part of our long-term commitment to supporting global medical device manufacturing, STERIS Applied Sterilization Technologies (AST) is pleased to announce that the Seriate, Italy microbiology laboratory has achieved ISO 17025 accreditation.
Details
October 3, 2024 – As part of our commitment to ensuring patient and consumer safety, STERIS is pleased to announce the construction of a new electron beam processing facility in Edmonton, Alberta, Canada.
Details